Eli Lilly and Co Investment Community Meeting Transcript
Good morning, everyone. Thanks for joining us at Eli Lilly and Company's 2021 Investment Community Meeting. I'm Kevin Hern, the Vice President of Investor Relations. I'd like to welcome individuals from the sell-side firms, institutional investors, rating agencies and media who are in the audience today here at the New York Stock Exchange. We're delighted you joined us, and we're excited to be here with you today. I'd like to also welcome those of you who are joining us by watching this event through the videocast on our website.
Lilly's purpose is to create new medicines that make life better for millions of people around the world. Today, we'll be highlighting the exciting opportunity we have to continue to fulfill that purpose for more patients as our newer medicines and potential upcoming launches drive further growth through the decade as well as showcase the next generation of assets across our 4 therapeutic areas that we believe will enable us to sustain the flow of innovation to patients and augment our future growth prospects.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |